Results 161 to 170 of about 23,093 (215)

Letter to Editor: Oral Isotretinoin in Recalcitrant Facial Flat Warts-Methodological and Reporting Gaps Undermine Generalizability. [PDF]

Health Sci Rep
Javed R, Iqbal J.
europepmc   +1 more source

Photodynamic Therapy with 5-Aminolevulinic Acid for Cosmetic-Induced Acne Fulminans: Case Report and Literature Review. [PDF]

Dermatol Pract Concept
An R, Liu R, Gu H.
europepmc   +1 more source

Sustained improvement of elastosis perforans serpiginosa after isotretinoin therapy

Sasan D. Noveir, Jessica Wu, Kathy Kim Langevin   +2 more
openalex   +1 more source

Ocular surface changes in the treatment of rosacea: comparison between low-dose oral isotretinoin and doxycycline

, 2019
Fábio Mendonça Xavier Andrade, Fabíola Rosa Picosse, Laura Pires da Cunha, Camila Maia Valente, Fernanda Machado Bezerra, Hélio Amante Miot, Ediléia Bagatin, Denise de Freitas   +7 more
openalex   +1 more source

The Impact of Isotretinoin on Lipid Profile: a Systematic Review. [PDF]

Ann Med Surg (Lond)
Sibi Krishna T, Kaur R, Malhotra V, Fatima Z, Mustajab M, Singh T, Iqbal M, Kesavan T, Ajeya SP, Mathew SG, Singh M.   +10 more
europepmc   +1 more source

Therapeutic Modulation of Demodex Density via Isotretinoin: Insights From a Prospective Dermatological Investigation. [PDF]

J Cosmet Dermatol
Chakmakchi AMJ, Alatas ET, Yurekli A, Aydoğdu CT, Demir Pektas S.   +4 more
europepmc   +1 more source

Abdominal diffuse dermal angiomatosis resolved with panniculectomy. [PDF]

JAAD Case Rep
DeVore S, Carrigan M, Ho J, Teunis T, English JC.   +4 more
europepmc   +1 more source

Mining and analysis of adverse event signals of isotretinoin based on the real-world data of FAERS database. [PDF]

Front Med (Lausanne)
Yang L, Xie H, Jia Y, Cui B, Xiao Z.
europepmc   +1 more source

Compliance with the European Pregnancy Prevention Programme in Isotretinoin Treatment: Safety Outcomes and Dose-Related Correlations. [PDF]

J Clin Med
Brzeziński P, Feszak IJ, Śmigielski J, Kawczak P, Bączek T.   +4 more
europepmc   +1 more source